Notably, the changes of plasma AFP and LDH levels, the proportion of CD16+CD56+ NK cells and CONUT scores at baseline tended to be associated with the treatment outcomes of advanced HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.